Home Biosimilar Antibodies Transmembrane Transporters Sodium Channel antibody Lifastuzumab (Anti-SLC34A2) For research use only.
Not for use in humans.

Lifastuzumab (Anti-SLC34A2)

Synonyms:

Lifastuzumab (Anti-SLC34A2) is a humanized monoclonal antibody targeting NaPi2b. MW : 145.5 KD.

Lifastuzumab (Anti-SLC34A2)

Purity & Quality Control

≥99

Choose Selective Sodium Channel Inhibitors

Biological Activity

Description Lifastuzumab (Anti-SLC34A2) is a humanized monoclonal antibody targeting NaPi2b. MW : 145.5 KD.

Product Details

CAS No. 1615697-16-9
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Lifastuzumab (Anti-SLC34A2) | Lifastuzumab (Anti-SLC34A2) supplier | purchase Lifastuzumab (Anti-SLC34A2) | Lifastuzumab (Anti-SLC34A2) cost | Lifastuzumab (Anti-SLC34A2) manufacturer | order Lifastuzumab (Anti-SLC34A2) | Lifastuzumab (Anti-SLC34A2) distributor